The University of Montreal, Canada, and its affiliated institutions have inked a license agreement providing Montreal-based Cognitive Sensing, Inc. (CSI) with exclusive worldwide rights to develop, manufacture, and market four products developed by Jocelyn Faubert, PhD, a professor in the university’s School of Optometry and CSI’s chief science officer. The partnership was facilitated by Gestion Univalor, Limited Partnership (Univalor), which commercializes technologies developed at the university. “Technologies created in [Professor Faubert’s] lab present exciting market opportunities in the medical, sports, and rejuvenation markets,” says Jean Castonguay, CEO of CSI, adding that the company has signed agreements to validate the first applications of the innovations. Under the licensing agreement, CSI will provide financial support for patent protection in various countries in addition to other payments.
The patented technologies include:
- MPI (mild perceptual impairment) device: An apparatus to diagnose and monitor brain trauma, concussions, Alzheimer’s disease, and other neurobiological conditions
- 3D-MOT (3D multiple object tracking): A device to enhance sports performance and to assess, train, and improve perception in people of all ages
- MSRS (multisensory stochastic resonance stimulation): A technology to improve sense and balance through auditory and visual stimulation
- Noisy bits: Software to improve image quality in standard displays and projectors by generating continuous luminance.
Source: Procto-Med